Amgen Submits Sotorasib New Drug Application To U.S. FDA For Advanced Or Metastatic Non-Small Cell Lung Cancer With KRAS G12C MutationPRNewsWire • 12/16/20
Amgen (AMGN) Dips More Than Broader Markets: What You Should KnowZacks Investment Research • 12/11/20
Amgen To Present First Clinical Data For BCMA-Targeted Half-Life Extended BiTE® Therapy AMG 701 At ASH 2020PRNewsWire • 12/05/20
Amgen and McKesson Launch Strategic Agreement to Advance Cancer Innovation in CommunitiesBusiness Wire • 12/04/20
World's Leading Life Science Companies Now Enrolling COMMUNITY, A Global, Platform Trial For Hospitalized Patients With COVID-19PRNewsWire • 11/30/20
Amgen (AMGN) Up 1.8% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 11/27/20